Company Aimmune Therapeutics, Inc.
Equities
AIMT
US00900T1079
Biotechnology & Medical Research
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Compliance Officer | 57 | 20-09-30 | |
Jim Pepin
LAW | General Counsel | - | - |
Samina Bari
PRN | Corporate Officer/Principal | - | - |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 65,450,142 | 50,930,993 ( 77.82 %) | 0 | 77.82 % |
Company contact information
Aimmune Therapeutics, Inc.
1007 US Highway 202/206 Building JR2
08807, Bridgewater
+650 614 5220
http://www.aimmune.comSector
1st Jan change | Capi. | |
---|---|---|
-1.51% | 105B | |
+3.22% | 97.5B | |
+1.86% | 22.19B | |
-16.53% | 21.33B | |
-8.49% | 18.68B | |
-42.33% | 16.6B | |
-20.09% | 14.52B | |
+5.47% | 14.09B | |
+28.85% | 10.99B |